Priority Date: 17.08.09 (US 20090234574P)

Combination therapy with antibodies and anti-VEGF agents for the treatment of cancer

  • Application ID: EP14151471
  • Status: GRANT OF PATENT INTENDED

Attorneys

no operation time available
Headquarter in Cambridge and 2 offices
active in Legal Services
no operation time available
Headquarter in Cambridge and 2 offices
active in Legal Services
no operation time available
Technology Company
no operation time available
Headquarter in Cambridge and 2 offices
active in Legal Services
no operation time available
Headquarter in Cambridge and 2 offices
active in Legal Services

Specialization

This patent has the IPC combination A61, C07, and C12 Avidity IP Ltd is specialized in the combination A61, C07, and C12. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 127 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.

Timeline

  • 17.08.2009 - Priority Date (US 20090234574P)
  • 23.04.2014 - Publication A1 (EP2722055)